Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Sensei Biotherapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Sensei Biotherapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights"
07/10/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/23/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Purchase Agreement, by and among Sensei Biotherapeutics, Inc., on the one hand, and Apeiron Investment Group Ltd., Presight Sensei Co-Invest Fund, L.P., Presight Sensei Co-Invest Management, L.L.C., Christian Angermayer, Apeiron SICAV Ltd. - Presight Capital Fund ONE, and Altarius Asset Management Ltd., on the other hand",
"Purchase Agreement, by and among Sensei Biotherapeutics, Inc., on the one hand, and Apeiron Investment Group Ltd., Presight Sensei Co-Invest Fund, L.P., Presight Sensei Co-Invest Management, L.L.C., Christian Angermayer, Apeiron SICAV Ltd. - Presight Capital Fund ONE, and Altarius Asset Management Ltd., on the other hand"
05/09/2023 8-K Quarterly results
Docs: "Sensei Biotherapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights"
04/20/2023 8-K Quarterly results
03/28/2023 8-K Quarterly results
03/13/2023 8-K Investor presentation
Docs: "Sensei Biotherapeutics, Inc. corporate presentation, dated March 2023"
03/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
03/07/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "Investor Contact"
02/06/2023 8-K Quarterly results
12/09/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amended and Restated Bylaws of Sensei Biotherapeutics, Inc., effective as of December 5, 2022",
"Amended and Restated Bylaws of Sensei Biotherapeutics, Inc., effective as of December 5, 2022"
12/08/2022 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Investor Contact:"
11/08/2022 8-K Investor presentation, Quarterly results
Docs: "Sensei Biotherapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights",
"Sensei Biotherapeutics, Inc. corporate presentation, dated November 2022"
09/30/2022 8-K Quarterly results
08/31/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
06/14/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
04/20/2022 8-K Investor presentation
Docs: "Presentation",
"Presentation"
03/10/2022 8-K Quarterly results
03/09/2022 8-K Quarterly results
01/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Company Presentation",
"Company Presentation"
12/06/2021 8-K Quarterly results
11/16/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Company Presentation"
11/09/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Sensei Biotherapeutics Reports Third Quarter 2021 Results and Recent Business Highlights"
09/08/2021 8-K Quarterly results
08/04/2021 8-K Quarterly results
08/02/2021 8-K Quarterly results
06/28/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
04/05/2021 8-K Quarterly results
03/25/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy